Search All Applications in Z-ARCHIVE-Cannabis
Application US20200330423
Published 2020-10-22
Oral Cannabinoid Tablet
The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1-106. (canceled)
- 107. An oral chewable tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles being particles consisting essentially of pure sugar alcohol, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.
- 108. (canceled)
- 132. An oral chewable tablet comprising a population of particles and one or more cannabinoids, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles being particles consisting essentially of sugar alcohol, the tablet being designed to turn into liquid within 20 seconds of mastication.
- 133. An oral chewable tablet comprising a population of particles and one or more cannabinoids, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles selected from non-DC particles of erythritol, maltitol, xylitol, isomalt, lactitol, mannitol, and combinations thereof, the tablet being designed to dissolve within 20 seconds of mastication.
